316 related articles for article (PubMed ID: 19884127)
1. Use of fertility drugs and risk of uterine cancer: results from a large Danish population-based cohort study.
Jensen A; Sharif H; Kjaer SK
Am J Epidemiol; 2009 Dec; 170(11):1408-14. PubMed ID: 19884127
[TBL] [Abstract][Full Text] [Related]
2. Risk of thyroid cancer after exposure to fertility drugs: results from a large Danish cohort study.
Hannibal CG; Jensen A; Sharif H; Kjaer SK
Hum Reprod; 2008 Feb; 23(2):451-6. PubMed ID: 18065402
[TBL] [Abstract][Full Text] [Related]
3. Risk of breast cancer after exposure to fertility drugs: results from a large Danish cohort study.
Jensen A; Sharif H; Svare EI; Frederiksen K; Kjaer SK
Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1400-7. PubMed ID: 17585058
[TBL] [Abstract][Full Text] [Related]
4. Uterine cancer after use of clomiphene citrate to induce ovulation.
Althuis MD; Moghissi KS; Westhoff CL; Scoccia B; Lamb EJ; Lubin JH; Brinton LA
Am J Epidemiol; 2005 Apr; 161(7):607-15. PubMed ID: 15781949
[TBL] [Abstract][Full Text] [Related]
5. Ovarian cancer risk after the use of ovulation-stimulating drugs.
Brinton LA; Lamb EJ; Moghissi KS; Scoccia B; Althuis MD; Mabie JE; Westhoff CL
Obstet Gynecol; 2004 Jun; 103(6):1194-203. PubMed ID: 15172852
[TBL] [Abstract][Full Text] [Related]
6. Malignant melanoma risk after exposure to fertility drugs: results from a large Danish cohort study.
Hannibal CG; Jensen A; Sharif H; Kjaer SK
Cancer Causes Control; 2008 Sep; 19(7):759-65. PubMed ID: 18340541
[TBL] [Abstract][Full Text] [Related]
7. Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs.
Althuis MD; Scoccia B; Lamb EJ; Moghissi KS; Westhoff CL; Mabie JE; Brinton LA
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 1):668-74. PubMed ID: 16150258
[TBL] [Abstract][Full Text] [Related]
8. Risk for borderline ovarian tumours after exposure to fertility drugs: results of a population-based cohort study.
Bjørnholt SM; Kjaer SK; Nielsen TS; Jensen A
Hum Reprod; 2015 Jan; 30(1):222-31. PubMed ID: 25376453
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer incidence after hormonal infertility treatment in Sweden: a cohort study.
Orgéas CC; Sanner K; Hall P; Conner P; Holte J; Nilsson SJ; Sundfeldt K; Persson I; Chia KS; Wedren S; Dickman PW; Czene K
Am J Obstet Gynecol; 2009 Jan; 200(1):72.e1-7. PubMed ID: 19121659
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer risk associated with ovulation-stimulating drugs.
Brinton LA; Scoccia B; Moghissi KS; Westhoff CL; Althuis MD; Mabie JE; Lamb EJ
Hum Reprod; 2004 Sep; 19(9):2005-13. PubMed ID: 15217997
[TBL] [Abstract][Full Text] [Related]
11. Risk of breast cancer and gynecologic cancers in a large population of nearly 50,000 infertile Danish women.
Jensen A; Sharif H; Olsen JH; Kjaer SK
Am J Epidemiol; 2008 Jul; 168(1):49-57. PubMed ID: 18448441
[TBL] [Abstract][Full Text] [Related]
12. Risk of endometrial cancer in women treated with ovary-stimulating drugs for subfertility.
Skalkidou A; Sergentanis TN; Gialamas SP; Georgakis MK; Psaltopoulou T; Trivella M; Siristatidis CS; Evangelou E; Petridou E
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010931. PubMed ID: 28349511
[TBL] [Abstract][Full Text] [Related]
13. Ovarian epithelial neoplasia after hormonal infertility treatment: long-term follow-up of a historical cohort in Sweden.
Sanner K; Conner P; Bergfeldt K; Dickman P; Sundfeldt K; Bergh T; Hagenfeldt K; Janson PO; Nilsson S; Persson I
Fertil Steril; 2009 Apr; 91(4):1152-8. PubMed ID: 18371964
[TBL] [Abstract][Full Text] [Related]
14. Childhood tumor risk after treatment with ovulation-stimulating drugs.
Brinton LA; Krüger Kjaer S; Thomsen BL; Sharif HF; Graubard BI; Olsen JH; Bock JE
Fertil Steril; 2004 Apr; 81(4):1083-91. PubMed ID: 15066468
[TBL] [Abstract][Full Text] [Related]
15. Risk of cholecystitis in patients with cancer: a population-based cohort study in Denmark.
Thomsen RW; Thomsen HF; Nørgaard M; Cetin K; McLaughlin JK; Tarone RE; Fryzek JP; Sørensen HT
Cancer; 2008 Dec; 113(12):3410-9. PubMed ID: 18951518
[TBL] [Abstract][Full Text] [Related]
16. Ovarian cancer after successful ovulation induction: a case report.
Hull ME; Kriner M; Schneider E; Maiman M
J Reprod Med; 1996 Jan; 41(1):52-4. PubMed ID: 8855076
[TBL] [Abstract][Full Text] [Related]
17. Assisted reproductive technology and the incidence of ovarian cancer: a meta-analysis.
Kashyap S; Moher D; Fung MF; Rosenwaks Z
Obstet Gynecol; 2004 Apr; 103(4):785-94. PubMed ID: 15051576
[TBL] [Abstract][Full Text] [Related]
18. Psychiatric disorders in women with fertility problems: results from a large Danish register-based cohort study.
Baldur-Felskov B; Kjaer SK; Albieri V; Steding-Jessen M; Kjaer T; Johansen C; Dalton SO; Jensen A
Hum Reprod; 2013 Mar; 28(3):683-90. PubMed ID: 23223399
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer risk associated with being treated for infertility: results from the French E3N cohort study.
Gauthier E; Paoletti X; Clavel-Chapelon F;
Hum Reprod; 2004 Oct; 19(10):2216-21. PubMed ID: 15271872
[TBL] [Abstract][Full Text] [Related]
20. Cellular telephone use and cancer risk: update of a nationwide Danish cohort.
Schüz J; Jacobsen R; Olsen JH; Boice JD; McLaughlin JK; Johansen C
J Natl Cancer Inst; 2006 Dec; 98(23):1707-13. PubMed ID: 17148772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
